Lobbying registrant

AVENUE SOLUTIONS

Open in network

Disclosed transactions0

Buys / sells0 / 0

Max Insider Score—

Connections15with evidence

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

Lobbied forevidence
AMGEN INCLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
Lobbied forevidence
VERTEX PHARMACEUTICALS INC / MALDA Q2 2026 second quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
Lobbied forevidence
Anthropic, PBCLDA Q1 2026 first quarter · Science/technology, Computer industry, Defense · Aug 26, 2026
Lobbied forevidence
Jazz Pharmaceuticals plcLDA Q2 2026 second quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
Lobbied forevidence
UNITEDHEALTH GROUP INCLDA Q1 2026 first quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
Lobbied forevidence
Moderna, Inc.LDA Q2 2026 second quarter · Health issues · Aug 26, 2026
Lobbied forevidence
COMPASS Pathways plcLDA RR 2026 second quarter · Health issues · Aug 26, 2026
Lobbied forevidence
ILLUMINA, INC.LDA Q1 2026 first quarter · Health issues, Trade · Aug 26, 2026
Lobbied forevidence
INCYTE CORPLDA Q1 2026 first quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
Lobbied forevidence
BRISTOL MYERS SQUIBB COLDA Q1 2026 first quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
Lobbied forevidence
ORACLE CORPLDA Q2 2026 second quarter · Health issues, VET, Computer industry · Aug 26, 2026
Lobbied forevidence
Edwards Lifesciences CorpLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
Lobbied forevidence
GRAIL, Inc.LDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
Lobbied forevidence
Apollo Global Management, Inc.LDA Q2 2026 second quarter · Health issues · Aug 26, 2026
Lobbied forevidence
Merck & Co., Inc.LDA Q2 2026 second quarter · Health issues, Medicare/Medicaid · Aug 26, 2026